In vitro, uPA derived from CAFs was found to promote esophageal squamous cell carcinoma (ESCC) cell proliferation, migration, and invasion by activating PI3K/AKT and ERK signaling pathways (65). The gene discussed is PLAU; the disease is esophageal squamous cell carcinoma.